The Relationship Between Proton Pump Inhibitor Use and Longitudinal Change in Bone Mineral Density: A Population-Based From the Canadian Multicentre Osteoporosis Study (CaMos)

OBJECTIVES: Proton pump inhibitor (PPI) use has been identified as a risk factor for hip and vertebral fractures. Evidence supporting a relationship between PPI use and osteoporosis remains scant. Demonstrating that PPIs are associated with accelerated bone mineral density (BMD) loss would provide s...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Am J Gastroenterol
Main Authors: Targownik, Laura E., Leslie, William D., Davison, K. Shawn, Goltzman, David, Jamal, Sophie A., Kreiger, Nancy, Josse, Robert G., Kaiser, Stephanie M., Kovacs, Christopher S., Prior, Jerilynn C., Zhou, Wei
Formato: Artigo
Idioma:Inglês
Publicado: 2012
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5104563/
https://ncbi.nlm.nih.gov/pubmed/22777336
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ajg.2012.200
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares